References
- Abra, R. M., Hunt, C. A. (1981). Liposome disposition in vivo. III. Dose and vesicle-size effects. Biochim Biophys Acta 666:493–503.
- Al-Angary, A. A., Bayomi, M. A., Khidr, S. H., Al-Meshal, M. A., Al-Dardiri, M. (1995). Characterization, stability, and in vivo targeting of liposomal formulations containing cyclosporine. Int J Pharm 114:221–225.
- Allen, T. M. (1994). The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv Drug Deliv Rev 13:285–309.
- Allen, T. M., Hansen, C., Rutledge, J. (1989). Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. Biochim Biophys Acta 981:27–35.
- Allen, T. M., Mehra, T., Hansen, C., Chin, Y. C. (1992). Stealth liposomes: an improved sustained release system for 1-beta-D arabinofuranosylcytosine. Cancer Res 52:2431–2439.
- Bally, M. B., Nayar, R., Masin, D., Hope, M. J., Cullis, P. R., Mayer, L. D. (1990). Liposomes with entrapped doxorubicin exhibit extended blood residence times. Biochim Biophys Acta 1023:133–139.
- Bangham, A. (1992). Liposomes: realizing their promise. Hosp Pract 12:51–62.
- Bangham, A. D., Standish, M. M., Watkins, J. C. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238–252.
- Burke, T. G., Gao, X. (1994). Stabilization of topotecan in low pH liposomes composed of distearoylphosphatidylcholine. J Pharm Sci 83:967–969.
- Cattel, L., Ceruti, M., Dosio, F. (2004). From conventional to stealth liposomes: a new frontier in cancer chemotherapy. J Chemother 16(Suppl. 4):94–97.
- Chonn, A., Semple, S. C., Cullis, P. R. (1991). Separation of large unilamellar liposomes from blood components by a spin column procedure: towards identifying plasma proteins which mediate liposome clearance in vivo. Biochim Biophys Acta 1070:215–222.
- Chonn, A., Semple, S. C., Cullis, P. R. (1992). Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. J Biol Chem 267:18759–18765.
- Cullis, P. R., Hope, M. J., Bally, M. B., Madden, T. D., Mayer, L. D., Fenske, D. B. (1997). Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides, and metal ions into large unilamellar vesicles. Biochim Biophys Acta 1331:187–211.
- Doroshaw, J. H. (1996). Anthracyclines and antracenediones. In: Chabner, B. A., Longo, D. L. (Eds.), Cancer chemotherapy and biotherapy: principles and practice (pp. 409–433). Philadelphia, Pennsylvania, USA: Lippincott-Raven.
- Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., Papahadjopoulos, D. (1999). Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 51:691–743.
- Ewer, M. S., Martin, F. J., Henderson, C., Shapiro, C. L., Benjamin, R. S., Gabizon, A. A. (2004). Cardiac safety of liposomal anthracyclines. Semin Oncol 31:161–181.
- Gabizon, A. A. (1995). Liposome circulation time and tumor targeting: implications for cancer chemotherapy. Adv Drug Deliv Rev 16:285–294.
- Gabizon, A. A., Barenholz, Y., Bialer, M. (1993). Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs. Pharm Res 10:703–708.
- Gabizon, A., Papahadjopoulos, D. (1988). Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci U S A 85:6949–6953.
- Gabizon, A., Papahadjopoulos, D. (1992). The role of surface charge and hydrophilic groups on liposome clearance in vivo. Biochim Biophys Acta 1103:94–100.
- Gabizon, A. A., Shiota, R., Papahadjopoulos, D. (1989). Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. J Natl Cancer Inst 81:1484–1488.
- Glavas-Dodov, M., Fredro-Kumbaradzi, E., Calıs, S., Gorasinova, K., Mladenovska, K., Simonovska, M., et al. (2004). Formulation and characterisation of 5-fluorouracil loaded liposomes. Bull Chem Technol (Macedonia) 23:13–18.
- Gradishar, W. J., Vokes, E. E. (1990). 5-Fluorouracil cardiotoxicity: a critical review. Ann Oncol 1:409–414.
- Haran, G., Cohen, R., Bar, L. K., Barenholz, Y. (1993). Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphiphatic weak bases. Biochim Biophys Acta 1151:201–215.
- Hwang, K. J. (1987). Liposome pharmacokinetics. In: Ostro, M. J. (Ed.), Liposomes: from biophysics to therapeutics (pp. 109–56). New York: Marcel Dekker.
- Klibanov, A. L., Maruyama, K., Torchilin, V. P., Huang, L. (1990). Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268:235–237.
- Krown, S. E., Northfelt, D. W., Osoba, D., Stewart, J. S. (2004). Use of liposomal anthracyclines in Kaposi’s sarcoma. Semin Oncol 31:36–52.
- Lammers, T., Kiessling, F., Hennink, W. E., Storm, G. (2011). Drug targeting to tumors: principles, pitfalls, and (pre-) clinical progress. J Control Release 161:175–187.
- Lasic, D. D., Martin, F. J., Gabizon, A., Huang, S. K., Papahadjopoulos, D. (1991). Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim Biophys Acta 1070:187–192.
- Lasic, D. D., Frederick, P. M., Stuart, M. C. A., Barenholz, Y., Mcintosh, T. J. (1992). Gelation of liposome interior: a novel method for drug encapsulation. FEBS Lett 312:255–258.
- Liu, D., Mori, A., Huang, L. (1992). Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. Biochim Biophys Acta 1104:95–101.
- Longley, D. B., Harkin, D. P., Johnston, P. G. (2003). 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3:330–338.
- Madden, T.D., Harrigan, P.R., Tai, L.C.L., Bally, M.B., Mayer, L.D., Redelmeier, T.E., et al. (1990). The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey. Chem Phys Lipids 53:37–46.
- Maeda, H., Wu, J., Sawa, T., Matsumura, Y., Hori, K. (2000). Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65:271–284.
- Maeda, H. (2001). The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41:189–207.
- Maeda, H., Sawa, T., Konno, T. (2001). Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 74:47–61.
- Markman, M., Gordon, A. N., McGuire, W. P., Muggia, F. M. (2004). Liposomal anthracycline treatment for ovarian cancer. Semin Oncol 31:91–105.
- Mosmann, T. (1993). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 95:55–63.
- Needham, D., McIntosh, T. J., Lasic, D. D. (1992). Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochim Biophys Acta 1108:40–48.
- Nounou, M. M., El-Khordagui, K. L., Khalafallah, N. A., Khalil, S. A. (2006). In vitro release of hydrophilic and hydrophobic drugs from liposomal dispersions and gels. Acta Pharm 56:311–324.
- Papahadjopoulos, D., Allen, T.M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S.K., et al. (1991). Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U S A 88:11460–11464.
- Perez-Soler, R. (1989). Liposomes as carriers of antitumor agents: towards a clinical reality. Cancer Treat Rev 16:67–82.
- Rose, P. G. (2005). Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer. Oncologist 10:205–214.
- Rouser, G., Fleischer, S., Yamamoto, A. (1970). Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5:494–496.
- Sausville, E. A., Longo, D. L. (2001). Principles of cancer treatment. In: Braunwald, E., Fauci, A. S., Kasper, D. L., Hauser, S. L., Longo, D. L., Jameson, J. L. (Eds.), Harrison’s principles of ınternal medicine (pp. 530–46). New York: McGraw-Hill.
- Senior, J. H. (1987). Fate and behaviour of liposomes in vivo: a review of controlling factors. CRC Crit Rev Ther Drug Carrier Syst 3:123–193.
- Senior, J., Delgado, C., Fisher, D., Tilcock, C., Gregoriadis, G. (1991). Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta 1062:77–82.
- Tilcock, C., Unger, E., Cullis, P., MacDougall, P. (1989). Liposomal Gd-DTPA: preparation and characterization of relaxivity. Radiology 171:77–80.
- Torchilin, V. P. (1996). Liposomes as delivery agents for medical imaging. Mol Med Today 2:242–249.
- Torchilin, V. P. (1998). Polymer-coated long-circulating microparticulate pharmaceuticals. J Microencapsul 15:1–19.
- Torchilin, V. P., Omelyanenko, V. G., Papisov, M. I., Bogdanov, A. A. Jr, Trubetskoy, V. S., Herron, J. N., et al. (1994). Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochim Biophys Acta 1195:11–20.
- Vaage, J., Donovan, D., Mayhew, E., Uster, P., Woodle, M. C. (1993). Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulated in sterically stabilized liposomes. Int J Cancer 54:959–964.
- Vail, D. M., Amantea, M. A., Colbern, G. T., Martin, F. J., Hilger, R. A., Working, P. K. (2004). Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studies. Semin Oncol 31:16–35.
- Woodle, M. C. (1993). Surface-modified liposomes: assessment and characterization for increased stability and prolonged blood circulation. Chem Phys Lipids 64:249–262.
- Woodle, M. C., Lasic, D. D. (1992). Sterically stabilized liposomes. Biochim Biophys Acta 1113:171–199.
- Woodle, M. C., Matthay, K. K., Newman, M. S., Hidayat, J. E., Collins, L. R., Redemann, C., et al. (1992) Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. Biochim Biophys Acta 1105:193–200.
- Young, R. C., Ozols, R. F., Myers, C. E. (1981). The anthracycline antineoplastic drugs. N Engl J Med 305:139–153.
- Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., et al. (1995). Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55:3752–3756.